Citius Pharmaceuticals, Inc. (CTXR)

Citius Pharmaceuticals Statistics

Total Valuation

CTXR has a market cap or net worth of $17.81 million. The enterprise value is $15.38 million.

Market Cap	17.81M
Enterprise Value	15.38M

Important Dates

The next estimated earnings date is Friday, February 13, 2026, after market close.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

CTXR has 20.76 million shares outstanding. The number of shares has increased by 64.49% in one year.

Current Share Class	20.76M
Shares Outstanding	20.76M
Shares Change (YoY)	+64.49%
Shares Change (QoQ)	+56.26%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	2.80%
Float	18.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	0.45
PS Ratio	n/a
Forward PS	0.38
PB Ratio	0.23
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.02.

Current Ratio	0.62
Quick Ratio	0.09
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-143.87

Financial Efficiency

Return on equity (ROE) is -52.42% and return on invested capital (ROIC) is -31.33%.

Return on Equity (ROE)	-52.42%
Return on Assets (ROA)	-19.45%
Return on Invested Capital (ROIC)	-31.33%
Return on Capital Employed (ROCE)	-44.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.63M
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTXR has paid $1.06 million in taxes.

Income Tax	1.06M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.76% in the last 52 weeks. The beta is 1.56, so CTXR's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-74.76%
50-Day Moving Average	1.06
200-Day Moving Average	1.17
Relative Strength Index (RSI)	40.50
Average Volume (20 Days)	1,559,704

Short Selling Information

The latest short interest is 3.17 million, so 15.25% of the outstanding shares have been sold short.

Short Interest	3.17M
Short Previous Month	2.63M
Short % of Shares Out	15.25%
Short % of Float	16.84%
Short Ratio (days to cover)	2.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.53M
Pretax Income	-38.68M
Net Income	-37.43M
EBITDA	-38.52M
EBIT	-38.53M
Earnings Per Share (EPS)	-$3.38

Balance Sheet

The company has $4.25 million in cash and $1.81 million in debt, with a net cash position of $2.44 million or $0.12 per share.

Cash & Cash Equivalents	4.25M
Total Debt	1.81M
Net Cash	2.44M
Net Cash Per Share	$0.12
Equity (Book Value)	77.53M
Book Value Per Share	3.74
Working Capital	-16.98M

Cash Flow

Operating Cash Flow	-26.55M
Capital Expenditures	n/a
Free Cash Flow	-26.55M
FCF Per Share	-$1.28

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTXR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.49%
Shareholder Yield	-64.49%
Earnings Yield	-210.13%
FCF Yield	-149.05%

Analyst Forecast

The average price target for CTXR is $6.00, which is 599.30% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	599.30%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 26, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Nov 26, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	2